CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants

CEL-SCI Corporation (NYSE MKT:

) ("CEL SCI" or the "Company") today announced that it has commenced an offering of common stock and warrants. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed. Dawson James Securities, Inc. is acting as the sole placement agent for the proposed offering on a best efforts basis. The offering will be made by CEL-SCI pursuant to a shelf registration statement on Form S-3 declared effective by the Securities and Exchange Commission ("SEC") on July 8, 2014. A preliminary prospectus supplement and accompanying prospectus related to the offering have been filed with the SEC and are available on the SEC's website located at http://www.sec.gov. Copies of the complete preliminary prospectus related to the offering may be obtained from Dawson James Securities, Inc., Attention: Prospectus Department, 1 North Federal Highway, 5th Floor, Boca Raton, FL 33432, mmaclaren@dawsonjames.com or toll free at 866.928.0928. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or other jurisdiction. The Company further announced that the proposed offering described above supercedes the proposed public offering announced on May 6, 2015 in which FBR Capital Markets and Co. was acting as the sole underwriter. FBR Capital Markets and Co. will not participate in the offering described above.